Intended for healthcare professionals

Letters Surgical mesh and safety

Mesh scandal: lessons from Wall Street ignored

BMJ 2018; 363 doi: (Published 13 November 2018) Cite this as: BMJ 2018;363:k4753
  1. Mark Wilson, bioethicist
  1. Guelph, ON, Canada N1G 6S4
  1. markwilson1920{at}

The mesh scandal is all too familiar.1 It joins a growing list of scandals where commercial conflicts of interest (COIs) and effective marketing of a defective product have led to serious injury and loss of life. Against the backdrop of Avandia, Vioxx, Praxil, the opioid crisis, and now the mesh scandal, one wonders what kind of tipping point is needed to prevent a …

View Full Text

Log in

Log in through your institution


* For online subscription